Deepak Talwar

3.0k total citations · 2 hit papers
44 papers, 1.5k citations indexed

About

Deepak Talwar is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Infectious Diseases. According to data from OpenAlex, Deepak Talwar has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 17 papers in Physiology and 9 papers in Infectious Diseases. Recurrent topics in Deepak Talwar's work include Chronic Obstructive Pulmonary Disease (COPD) Research (14 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers) and Respiratory Support and Mechanisms (8 papers). Deepak Talwar is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (14 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers) and Respiratory Support and Mechanisms (8 papers). Deepak Talwar collaborates with scholars based in India, United States and France. Deepak Talwar's co-authors include Márcio Nucci, Robert F. Betts, Barbara G. Utterback, Álvaro Réa-Neto, Rekha Garg, William L. Macias, Howard Levy, Edward Abraham, Bruno François and Rolf Rossaint and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Deepak Talwar

38 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death

2005 567 citations Edward Abraham, Pierre‐François Laterre et al. New England Journal of Medicine profile →
Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis

2007 478 citations Peter G. Pappas, Robert F. Betts et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deepak Talwar India	9	1.0k	757	232	177	136	44	1.5k
James Spalding United States	24	546 0.5×	786 1.0×	403 1.7×	86 0.5×	90 0.7×	58	2.3k
Pierre Bulpa Belgium	12	919 0.9×	1.0k 1.3×	438 1.9×	187 1.1×	62 0.5×	28	1.6k
Brad Moriyama United States	19	486 0.5×	542 0.7×	150 0.6×	73 0.4×	160 1.2×	22	1.2k
Ben van der Hoven Netherlands	19	653 0.7×	511 0.7×	188 0.8×	156 0.9×	47 0.3×	48	1.6k
Francesco Menichetti Italy	17	512 0.5×	499 0.7×	124 0.5×	111 0.6×	178 1.3×	51	1.4k
A de Roux Germany	19	1.2k 1.2×	402 0.5×	425 1.8×	207 1.2×	95 0.7×	35	1.8k
Wendy Sligl Canada	22	750 0.7×	456 0.6×	188 0.8×	274 1.5×	67 0.5×	58	1.6k
Tobias Lahmer Germany	22	426 0.4×	488 0.6×	270 1.2×	165 0.9×	75 0.6×	101	1.5k
Donghui Yu China	21	391 0.4×	375 0.5×	98 0.4×	66 0.4×	92 0.7×	37	1.2k
Nattachai Srisawat Thailand	29	606 0.6×	315 0.4×	221 1.0×	477 2.7×	98 0.7×	149	2.6k

Countries citing papers authored by Deepak Talwar

Since Specialization

Citations

This map shows the geographic impact of Deepak Talwar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepak Talwar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepak Talwar more than expected).

Fields of papers citing papers by Deepak Talwar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepak Talwar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepak Talwar. The network helps show where Deepak Talwar may publish in the future.

Co-authorship network of co-authors of Deepak Talwar

This figure shows the co-authorship network connecting the top 25 collaborators of Deepak Talwar. A scholar is included among the top collaborators of Deepak Talwar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepak Talwar. Deepak Talwar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jeny, Florence, Deepak Talwar, Ogugua Ndili, et al.. (2024). Sarcoidosis Diagnostic Score (SDS) system: Impact of race, sex, organ involvement and duration of symptoms prior to diagnosis. Respiratory Medicine and Research. 86. 101127–101127.

Arora, V.K., S K Katiyar, Deepak Talwar, et al.. (2023). Genomic revolution: Transforming tuberculosis diagnosis and treatment with the use of Whole Genome Sequencing - A consensus statement. Indian Journal of Tuberculosis. 70(4). 383–389. 2 indexed citations

Talwar, Deepak, et al.. (2022). The Effect of a Short-Term Pulmonary Rehabilitation on Exercise Capacity and Quality of Life in Patients Hospitalised with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. The Indian Journal of Chest Diseases and Allied Sciences. 56(1). 13–19. 4 indexed citations

Dhar, Raja, et al.. (2022). Use of single-inhaler triple therapy in the management of obstructive airway disease: Indian medical experts’ review. ERJ Open Research. 8(1). 556–2021. 5 indexed citations

Talwar, Deepak, et al.. (2021). Type 2 myocardial infarction in COVID19: World's first case series. 25(113). 1583–1588. 2 indexed citations

Talwar, Deepak, et al.. (2021). Post covid hypothalamic- pituitary-adrenal axis dysfunction manifesting as perinatal depression: A case series. 25(112). 1402–1406. 7 indexed citations

Talwar, Deepak, et al.. (2021). Facial colliculus syndrome with inflammatory cranial neuritis in a patient with covid 19 with mucormycosis superinfection. 25(113). 1517–1521. 2 indexed citations

Talwar, Deepak, et al.. (2021). Asymptomatic Bradycardia in COVID-19: Premonition of a cytokine storm?. 25(112). 1291–1294. 1 indexed citations

Talwar, Deepak, et al.. (2021). Acute suicidal psychotic illness in mentally healthy patient: Is it COVID-19?. 25(112). 1277–1280. 2 indexed citations

10.

Patel, Mukund R., et al.. (2021). Cutaneous mucormycosis with maxillary sinus fistula as a presenting feature of COVID-19: A rare case report. 25(113). 1507–1512. 3 indexed citations

11.

Gerke, Alicia K., Elyse E. Lower, А. A. Vizel, et al.. (2021). The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study. Respiratory Medicine. 187. 106564–106564. 33 indexed citations

12.

Talwar, Deepak, et al.. (2021). The emerging role of nebulization for maintenance treatment of chronic obstructive pulmonary disease at home. Lung India. 38(2). 168–173. 5 indexed citations

13.

Moiz, Jamal Ali, et al.. (2020). Effect of Pulmonary Rehabilitation in Patients with Asthma COPD Overlap Syndrome: A Randomized Control Trial. Oman Medical Journal. 35(3). e136–e136. 10 indexed citations

14.

Moiz, Jamal Ali, et al.. (2018). Reliability, Validity, and Responsiveness of the Incremental Shuttle Walk Test in Patients With Interstitial Lung Disease. Journal of Cardiopulmonary Rehabilitation and Prevention. 38(6). 425–429. 11 indexed citations

15.

Bhattacharya, Amal, et al.. (2016). Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD. International Journal of COPD. Volume 11. 1469–1476. 2 indexed citations

16.

Guleria, Randeep, et al.. (2013). Asthma diagnosis and treatment – 1015. Improvements in lung function in an indian population with IgE mediated asthma receiving omalizumab in a real-world setting. World Allergy Organization Journal. 6. P15–P15. 1 indexed citations

17.

Betts, Robert F., Márcio Nucci, Deepak Talwar, et al.. (2009). A Multicenter, Double‐Blind Trial of a High‐Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis. Clinical Infectious Diseases. 48(12). 1676–1684. 172 indexed citations

18.

Pappas, P. G., Márcio Nucci, Deepak Talwar, et al.. (2008). Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis (vol 45, pg 883, 2007). Ghent University Academic Bibliography (Ghent University). 108 indexed citations

19.

Pappas, Peter G., Robert F. Betts, Márcio Nucci, et al.. (2007). Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis. Clinical Infectious Diseases. 45(7). 883–893. 478 indexed citations breakdown →

20.

Abraham, Edward, Pierre‐François Laterre, Rekha Garg, et al.. (2005). Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death. New England Journal of Medicine. 353(13). 1332–1341. 567 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact